首页|期刊导航|中华医学杂志(英文版)|Incidence,mortality,and disability-adjusted life years of female breast cancer in China,2022

Incidence,mortality,and disability-adjusted life years of female breast cancer in China,2022OACSTPCDMEDLINE

Incidence,mortality,and disability-adjusted life years of female breast cancer in China,2022

Kexin Sun;Yifei Yao;Peiqing Ma;Shaoming Wang;Ru Chen;Bingfeng Han;Wenqiang Wei;Jie He;Bailin Zhang;Shaoyuan Lei;Rongshou Zheng;Xin Liang;Li Li;Xiaolong Feng;Siwei Zhang;Hongmei Zeng

Office of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Pathology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Thoracic Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Breast Surgical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Evidence-Based Medicine,Xuanwu Hospital,Capital Medical University,Beijing 100053,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaMedical Statistics Office,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Pathology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China

FemaleBreast cancerIncidenceMortalityDALYsChinaEarly detection of cancerDisease burdenInvasive breast carcinomaQuality of life

FemaleBreast cancerIncidenceMortalityDALYsChinaEarly detection of cancerDisease burdenInvasive breast carcinomaQuality of life

《中华医学杂志(英文版)》 2024 (20)

2429-2436,8

This work was supported by a grant from the CAMS Innovation Fund for Medical Sciences(No.2021-I2M-1-011).

10.1097/CM9.0000000000003278

评论

您当前未登录!去登录点击加载更多...